FDA Scolds Drugmakers For Missing Pediatric Study Deadlines
The U.S. Food and Drug Administration on Monday accused Genzyme Corp. and two other drugmakers of failing to satisfy obligations to study previously approved products in children, the first examples of...To view the full article, register now.
Already a subscriber? Click here to view full article